Literature DB >> 7296797

Hemodynamic determinants of pulmonary valve motion during systole in experimental pulmonary hypertension.

M Tahara, H Tanaka, S Nakao, H Yoshimura, S Sakurai, C Tei, T Kashima.   

Abstract

To clarify the determinants of pulmonary valve (PV) motion in pulmonary hypertension, we examined the correlations among PV echo patterns, the pulmonary artery (PA) flow curve just above the PA orifice and the pulmonary artery-right ventricle (PA-RV) pressure gradient. By constricting the PA, we could produce a variety of PV echo patterns, including midsystolic semiclosure in open-chest dogs. Throughout the experiments, the PV echo pattern and PA flow curve were similar in pattern and timing. When the PV echo showed midsystolic semiclosure with reopening. The PA flow curve showed a transient decrease followed by a transient increase during midsystole. The PA-RV pressure gradient became transiently positive (PA pressure greater than RV pressure) and then negative in midsystole only when the PV echo showed midsystolic semiclosure with reopening. In conclusion, PV motion during systole may be instantaneously determined by PA flow change and the PA-RV pressure gradient during the cardiac cycle in experimental pulmonary hypertension.

Entities:  

Mesh:

Year:  1981        PMID: 7296797     DOI: 10.1161/01.cir.64.6.1249

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Assessment of pulmonary arterial hypertension and vascular resistance by measurements of the pulmonary arterial flow velocity curve in the absence of a measurable tricuspid regurgitant velocity in childhood congenital heart disease.

Authors:  Ayhan Cevik; Serdar Kula; Rana Olgunturk; F Sedef Tunaoglu; A Deniz Oguz; Berna Saylan; Erman Cilsal; Cihat Sanli
Journal:  Pediatr Cardiol       Date:  2012-10-05       Impact factor: 1.655

2.  Correlation between velocity measurements from Doppler echocardiography and from M-mode contrast echocardiography.

Authors:  R S Meltzer; B Diebold; N K Valk; D Blanchard; J L Guermonprez; C T Lancée; P Peronneau; J Roelandt
Journal:  Br Heart J       Date:  1983-03

3.  Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension.

Authors:  Lydia C Soydan; Heidi B Kellihan; Melissa L Bates; Rebecca L Stepien; Daniel W Consigny; Alessandro Bellofiore; Christopher J Francois; Naomi C Chesler
Journal:  J Vet Cardiol       Date:  2015-01-16       Impact factor: 1.701

4.  Quantitative assessment of pulmonary vascular resistance and reactivity in children with pulmonary hypertension due to congenital heart disease using a noninvasive method: new Doppler-derived indexes.

Authors:  Yayaoi Nakahata; Satoshi Hiraishi; Natsuko Oowada; Hisashi Ando; Sumito Kimura; Shinsuke Furukawa; Shohei Ogata; Masahiro Ishii
Journal:  Pediatr Cardiol       Date:  2008-10-28       Impact factor: 1.655

5.  Reliability of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography.

Authors:  M Matsuda; T Sekiguchi; Y Sugishita; K Kuwako; K Iida; I Ito
Journal:  Br Heart J       Date:  1986-08

6.  Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience.

Authors:  Christine L Jellis; Margaret M Park; Aiden Abidov; Barry A Borlaug; Evan L Brittain; Robert Frantz; Paul M Hassoun; Evelyn M Horn; Wael A Jaber; Kim Jiwon; Maria G Karas; Deborah Kwon; Jane A Leopold; Bradley Maron; Stephen C Mathai; Reena Mehra; Franz Rischard; Erika B Rosenzweig; W H Wilson Tang; Rebecca Vanderpool; James D Thomas
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 9.130

7.  Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI.

Authors:  Q Joyce Han; Walter R T Witschey; Christopher M Fang-Yen; Jeffrey S Arkles; Alex J Barker; Paul R Forfia; Yuchi Han
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.